Tags |
|
|
Links |
|
|
Digg It - Lawyer Annual Renewals with Audits Needed
Due to Sarbanes Oxley so many Corporations and Small Medium Sized companies ar
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
e feeling the incessant costs of increasing accounting fees. This is because t
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
here are not enough accountants to do all the work and because errors and omis
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
sions insurance have gone up because trial lawyers are using these laws to sue
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
companies and accounting firms.
It is also causing many small accounting cor
It is also causing many small accounting cor
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
porations from no longer wishing to do audits, which are required by the rules
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
and regulations. What we need is more rules and regulations for lawyers and
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
a way to prove that they are all honest in their dealings.
I personally do no
I personally do no
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
t believe that any lawyer is honest and I believe they should all be; well, Ca
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
esar said it best. We need to give all lawyers annual lie detector tests and w
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
e must make sure that all lawyers have annual audits of their books so that we
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
can see who is paying them and what they are doing with their money and which
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
politicians they are funding and exactly what is going on.
If we want to cle
If we want to cle
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
an up the corruption in Washington D.C. and we wish to have a level playing fi
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
eld then we must keep the lawyers honest with rules and regulations and monito
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
r the situation. Then we must watch the lawyers like a hawk and take away the
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ir law licenses if they cheat. This is the only way to insure that lawyers do
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
not work above the law and rather work for their clients within the law, then
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
of course we must reduce the rules and regulations for everyone else. Conside
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
r this in 2006 and no more of this over billing, those bastards (opinion only)
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/22562/diggit-Lawyer-Annual-Renewals-with-Audits-Needed.html">Lawyer Annual Renewals with Audits Needed</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/22562/diggit-Lawyer-Annual-Renewals-with-Audits-Needed.html]Lawyer Annual Renewals with Audits Needed[/url]
Related Articles:
Call Center Marketing Services
Bookmark it:
|